TCMs Not Paxlovid Gain Traction As Beijing On High Alert
But WHO Cautious On Findings
As Shanghai enters a second week of a city-wide lockdown with no signs of policy easing, officials are promoting the use of traditional Chinese medicines rather than Pfizer's recently approved Paxlovid.
